A detailed history of Pointe Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Pointe Capital Management LLC holds 10,589 shares of PFE stock, worth $293,527. This represents 0.18% of its overall portfolio holdings.

Number of Shares
10,589
Previous 11,035 4.04%
Holding current value
$293,527
Previous $317,000 7.57%
% of portfolio
0.18%
Previous 0.22%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$25.89 - $29.73 $11,546 - $13,259
-446 Reduced 4.04%
10,589 $293,000
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $21,672 - $25,074
600 Added 5.75%
11,035 $404,000
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $11,501 - $14,973
292 Added 2.88%
10,435 $425,000
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $18,208 - $22,562
-398 Reduced 3.78%
10,143 $525,000
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $5,412 - $8,023
-131 Reduced 1.23%
10,541 $622,000
Q3 2021

Oct 29, 2021

BUY
$39.25 - $50.42 $8,988 - $11,546
229 Added 2.19%
10,672 $459,000
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $1,580 - $1,789
44 Added 0.42%
10,443 $409,000
Q1 2021

May 11, 2021

BUY
$33.49 - $37.77 $837 - $944
25 Added 0.24%
10,399 $377,000
Q3 2020

Nov 05, 2020

SELL
$31.75 - $37.25 $28,003 - $32,854
-882 Reduced 7.84%
10,374 $381,000
Q1 2020

May 11, 2020

BUY
$27.03 - $38.62 $52,465 - $74,961
1,941 Added 20.84%
11,256 $367,000
Q2 2019

Aug 08, 2019

BUY
$36.98 - $41.52 $344,468 - $386,758
9,315 New
9,315 $403,000
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $272,777 - $290,808
-8,271 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$31.91 - $37.02 $2,808 - $3,257
88 Added 1.08%
8,271 $294,000
Q4 2017

Jan 12, 2018

SELL
$33.26 - $35.29 $8,847 - $9,387
-266 Reduced 3.15%
8,183 $296,000
Q3 2017

Oct 16, 2017

BUY
$31.0 - $34.15 $261,919 - $288,533
8,449
8,449 $302,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Pointe Capital Management LLC Portfolio

Follow Pointe Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pointe Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pointe Capital Management LLC with notifications on news.